For an in-depth look at our programs and technologies, please see our corporate presentation. View Presentation
MeiraGTx is a clinical-stage genetic medicine company committed to harnessing the full potential of genetic therapies for both rare and prevalent diseases.
MeiraGTx is pioneering transformative technologies that allow precision control of gene expression. Our riboswitch gene regulation platform allows unprecedented spatial and temporal control of transgene expression, with broad implications for the applicability of genetic medicines for treating a wide range of disorders not limited to inherited diseases.
Each day we work to improve the lives of patients through cutting-edge science designed to treat their specific disease. We believe each patient deserves the best treatment possible, and with our highly flexible genetic medicine platform and end-to-end manufacturing ecosystem, we believe we can deliver on that promise.
